poisar

Stocks · News reference

Nutriband Files U.S. Patent Application To Increase Protection For Its AVERSA Abuse Deterrent Transdermal Technology

BenzingaBenzinga Newsdesk

This new patent application covers improved aversive formulations and coating application methods to enhance the abuse deterrent properties of Nutriband’s AVERSA™ transdermal technology and make it even more difficult

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Nutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System

    Nutriband Inc. received a USPTO Notice of Allowance for commercial brand name trademarks for its abuse-deterrent fentanyl transdermal patch incorporating AVERSA™ technology. The company is preparing preapproval regulatory submissions for the FDA, EMA, and international agencies, with peak annual U.S. sales potential estimated between $80-200 million.